Global Vitamin D Market - Outlook and Forecast 2022-2027

Market Overview

The global vitamin D market experienced significant growth in recent years and is projected to continue expanding at a compound annual growth rate (CAGR) of 8.49% from 2021 to 2027. Its value is expected to reach USD 2.68 billion by 2027, representing an incremental revenue of over USD 1 billion during the forecast period. The market’s growth can be attributed to its application in various industries, including nutricosmetics, premixes, functional beverages, and the vegan sector.

The vitamin D market is highly competitive, with numerous key vendors vying for market share. In this competitive landscape, clinically proven formulas and scientific research play a significant role in differentiating products. Suboptimal levels of micronutrients, such as vitamins and minerals, are prevalent in more than one-third of the global population. Vitamin D deficiency affects over 1 billion people worldwide, primarily due to inadequate diet and insufficient exposure to sunlight. Factors such as geography, culture, and demographics also contribute to varying vitamin D levels.

Product Type

Market Report

No. of Pages


Release Date

January 2023

Base Year


Forecast Period


Market Size

USD 1.6 billion in 2020

Market Segments

Analog, Form, Application, End User, and Geography



No. of Companies Mentioned


The demand for supplements and functional foods is a notable characteristic of the vitamin D market. The COVID-19 pandemic has further accelerated this growth, along with increasing nutrition requirements, government initiatives, and substantial investments in end-user industries.

Vitamin D has been extensively studied for its impact on various biological processes, including calcium and phosphorus metabolism, cell division, immunological control, and neurogenesis. Recent research has also revealed associations between vitamin D and illnesses such as cancer, autoimmune diseases, viral infections, and cardiovascular disorders. The role of the vitamin D system in cancer prevention and treatment has received considerable attention. Clinical trials suggest that vitamin D may have a greater impact on cancer mortality and survival rather than incidence. Laboratory and animal studies indicate that vitamin D may help inhibit tumor development and prevent cancer cell growth.

Topical skincare products containing vitamin D have gained recognition among dermatologists for their beneficial effects. Vitamin D3 creams, especially those with 5,000 IU, are believed to have therapeutic effects on conditions like psoriasis. Oil-based vitamin D3 solutions are recommended for treating psoriasis. Over-the-counter vitamin D beauty products are readily available and contribute to the market’s growth by protecting the skin, preventing aging, and promoting normal cell turnover. Rejuvenating and protective properties of vitamin D3 make it a valuable ingredient in topical skincare formulations, further driving market expansion.

Vitamin D insufficiency is a widespread medical condition globally, leading to poor bone health and an increased risk of various illnesses such as type 1 diabetes, certain cancers, autoimmune diseases, and cardiovascular problems. A significant percentage of the population, ranging from 30% to 50%, suffers from vitamin D deficiency in countries like the US, Canada, Australia, Europe, New Zealand, and Asia. Additionally, over 50% of the population has insufficient levels of vitamin D. Certain regions, such as Europe, have higher rates of deficiency, with around 40% of the population estimated to be deficient. Severe cases of vitamin D deficiency can result in osteoporosis, hip fractures, and rickets, a condition characterized by softening of the bones, fractures, and deformities, primarily affecting children. Depression, bone pain, and weakness are also associated with vitamin D deficiency. Increased awareness of the importance of vitamin D contributes to the growth of the global vitamin D market.

Market Segmentation

The market is segmented based on various factors, including analog, form, application, end user, and geography.

Segmentation by Application
Animal Health
Functional Food and Beverages
Personal Care

Segmentation by Form

Segmentation by Analog
Vitamin D2
Vitamin D3

Segmentation by End User

Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain, Russia, Poland
APAC – China, Japan, India, South Korea, Australia, Indonesia, Vietnam, Thailand, Malaysia
Latin America – Brazil, Mexico, Argentina, Columbia
Middle East & Africa – South Africa, Saudi Arabia, Turkey

In 2021, the pharmaceuticals segment held a significant share of 48.07% in the global vitamin D market. This can be attributed to the dominance of the pharmaceutical industry in the market, driven by the increasing application of vitamin D in new segments such as vitamin therapy and beauty supplements. Vitamin D plays a crucial role in promoting calcium absorption in the body, making it essential for most pharmaceutical companies. With a rising number of deficiencies and medical complications related to vitamin D in both children and adults, its importance in the pharmaceutical industry is undeniable. Additionally, vitamin D is considered a growth hormone that is vital for bone growth and mineralization in children. Pregnant women also contribute to the demand for vitamin D consumption through supplements. The deficiency of vitamin D can lead to hypovitaminosis D.

There are two main forms of vitamin D: dry and liquid. The dry segment holds a major share of approximately 71.99% in the global vitamin D market. This dominance can be attributed to the higher stability and extended shelf life of dry vitamin D. The dry segment includes beadlets and crystalline forms that are used in various industries such as pharmaceuticals, animal feed, and cosmetics. Dry vitamin D is highly preferred in cattle feed, with pregnant heifers requiring up to 1,887 IU/kg of vitamin D daily. Dry forms are also commonly used in supplements due to their higher potency and effectiveness. The increasing demand for encapsulated forms and premix formulas is expected to drive the growth of the dry vitamin D market segment. Moreover, expansions in the animal feed industry, particularly in countries like China, the US, and India, have the potential to further enhance the market value. Dry forms of vitamin D3 are also popular in European markets such as Sweden, Germany, France, the UK, Spain, and Russia.

Among all the analogs, the vitamin D3 segment holds a significant share of around 69.58% in the global vitamin D market. This dominance can be attributed to the fact that vitamin D3 is the biologically active form of vitamin D found in both humans and animals. Vitamin D3 is used in supplements, animal feed, and cosmetics due to its unique advantages in terms of shelf life, activity, and bio-activeness compared to other forms. The demand for vitamin D3 has increased significantly following the outbreak of the COVID-19 pandemic, and it is expected that new formulations with vitamin D3 as a vital ingredient will be developed in the next five years.

In the end-user category, the human segment holds the highest share of approximately 66.98% in the global vitamin D market. This can be attributed to the fact that vitamin D supplementation is considered the most appropriate treatment option for the adult population. Due to inadequate sun exposure, it is challenging to obtain sufficient vitamin D levels from dietary sources alone. As a result, many specialists recommend dietary supplements as a safe and cost-effective alternative for treating vitamin D deficiency. The Institute of Medicine (IOM) has recently issued new dietary guidelines for vitamin D supplementation. According to these guidelines, children over the age of 1 and adults up to 70 should take 600 IU of vitamin D daily, while adults over 70 should take 800 IU daily. Several factors contribute to vitamin D deficiency in the elderly, including reduced sun exposure, minimized outdoor activities, decreased efficiency of vitamin D synthesis due to aging skin, decreased appetite, and malabsorption of nutrients. Vitamin D deficiency during pregnancy is also a global concern, with studies showing a prevalence ranging from 18 to 84% in pregnant women. Sufficient intake of calcium and vitamin D is crucial for calcium homeostasis, fetal growth, and bone mineralization during pregnancy.

Europe holds a significant share of approximately 28.03% in the global vitamin D market. This can be attributed to the increased usage of nutricosmetics, changing lifestyles, and the strong presence of pharmaceutical companies in the region, which is expected to drive growth in the coming years. In 2021, major revenue-generating countries in Europe included Germany, France, the UK, Spain, and Italy. The region is home to various industries such as pharmaceuticals, functional food and beverages, animal feed, and personal care, all of which require vitamin D for manufacturing drugs, animal feed supplements, dietary supplements, and personal care products. Other significant markets for vitamin D in Europe include the Netherlands, Switzerland, Denmark, and Belgium, particularly in the animal feed, cosmetics, and supplement segments. Deficiency of vitamin D is prevalent in the general population of Europe, making it one of the best markets for the penetration of vitamin D products, as more than 70% of the population is either deficient or insufficient.

The growing number of vegans and vegetarians in the region has fueled the demand for vegan-enriched foods and dietary supplements. Vitamin D3, with its stability and durability, is particularly suitable for use in dietary supplements. However, this trend could pose challenges for pharmaceutical companies in the region and impact the demand for vitamin D products. Additionally, the COVID-19 pandemic has led to increased sales of vitamin D supplements in Spain.

Competitive Landscape

The vitamin D market comprises several renowned multinational and regional chemical companies, including DSM, BASF, Fermenta Biotech, Dishman Carbogen, and Zhejiang Garden Biochemical High-Tech. These leading players, such as BASF, consider vitamin D3 as one of their premium ingredients. Vitamin D3 is highly temperature-stable, capable of withstanding temperatures of up to 77°F (25°C), and has a longer shelf life compared to other forms. This ingredient can be utilized in various product forms, including dietary supplements, functional food and beverages, medicinal food, and food fortification.

As the vitamin D market evolves, we can expect the emergence of new vendors specializing in the production of vitamin supplements. These new entrants may present potential opportunities for vitamin D manufacturers to form partnerships or collaborations. In this digital age, maintaining consistent online engagement is crucial for lead generation, as e-commerce platforms play a significant role in the wholesale market. Furthermore, leveraging e-commerce channels not only facilitates business transactions but also enhances the overall end-user experience.

Key companies profiled in this report include BASF SE, Fermenta Biotech Limited, DSM, Dishman Carbogen Amcis, Zhejiang Garden Biochemical High-Tech Co Ltd, Adisseo, Synthesia, Vitablend, NewGen Pharma, Sichuan Neijiang Huixin Pharmacy, HangZhou Think Chemical, Lycored, Pharmavit, Divi’s Nutraceuticals, Tocris Bioscience, Spectrum Chemical, Stabicoat Vitamins, Xiamen Kingdomway Group Company, Zhejiang NHU.

Key Questions Answered

What is the current market value of the vitamin D industry?

The global market for vitamin D was valued at USD 1.64 billion in 2021.

What is the projected growth rate for the global vitamin D market?

The global vitamin D market is expected to grow at a compound annual growth rate (CAGR) of 8.49% from 2022 to 2027.

What are some emerging trends in the global vitamin D market?

Some emerging trends in the global vitamin D market include the increasing use of vitamin D in therapeutic applications, rising demand for vitamin D formulations in personal care products, the growing popularity of vegan vitamin D formulations, and the development of new drug delivery technologies for administering vitamin D.

How large is the vitamin D market in North America?

The North American vitamin D market had a valuation of USD 431.15 million in 2021 and is projected to reach USD 695.80 million by 2027.

Who are the key players driving the growth of the vitamin D market?

Prominent players influencing the growth of the vitamin D market include BASF SE, Fermenta Biotech Limited, DSM, Dishman Carbogen Amcis, and Zhejiang Garden Biochemical High-Tech Co Ltd.

Which region holds the largest market share for vitamin D globally?

Europe currently holds the largest market share in the global vitamin D market, accounting for 28.03% of the total market. The European region is expected to experience significant growth, with an absolute growth of 58.08% during the forecast period.

Original price was: USD 4,200.Current price is: USD 2,520.

Want to customize this report? Our industry specialist will collaborate with you to deliver tailored data within a limited timeframe.
Scroll to Top

Request Free Sample Report

Global Vitamin D Market - Outlook and Forecast 2022-2027

Please fill out our form and we will get back to you.


Global Vitamin D Market - Outlook and Forecast 2022-2027

Please fill out our form and we will get back to you.